Alcohol-associated fatty liver disease vs Metabolic dysfunction-associated steatotic liver disease
How to tell Alcohol-associated fatty liver disease and Metabolic dysfunction-associated steatotic liver disease apart when a board question makes them look alike.
Alcohol exposure and AST:ALT near 2:1 point alcohol-associated disease; metabolic syndrome without alcohol points MASLD/NAFLD.
Side by side
Fatty liver or steatohepatitis with meaningful alcohol exposure, AST greater than ALT often near 2:1, macrocytosis, or alcoholic hepatitis clues.
Fatty liver disease tied to obesity, insulin resistance, type 2 diabetes, dyslipidemia, and metabolic syndrome without significant alcohol use; older wording is NAFLD.
Alcohol metabolism changes hepatic redox state, promotes triglyceride accumulation, oxidative stress, inflammation, and fibrosis.
Insulin resistance drives hepatic fat accumulation, lipotoxicity, inflammation, and possible progression to steatohepatitis and fibrosis.
AST:ALT near 2:1, elevated GGT, macrocytosis, and alcohol history support alcohol-associated disease.
Metabolic syndrome, ALT-predominant mild transaminase elevation, and imaging steatosis support MASLD, formerly called NAFLD.
The trap
Both can progress from steatosis to steatohepatitis, cirrhosis, and hepatocellular carcinoma.
The repair move
For fatty liver, decide whether the driver is alcohol metabolism or insulin-resistance metabolism.
Try a free question
CoreA patient with heavy alcohol use has AST greater than ALT in an approximately 2:1 pattern, macrocytosis, tender hepatomegaly, and steatohepatitis. Which diagnosis is most likely?
Show answer and explanation
Answer: A. Alcohol-associated fatty liver disease. Alcohol-associated liver disease classically has AST greater than ALT, often around 2:1, with alcohol exposure clues.
Why the other choices are tempting
- B. MASLD/NAFLD is linked to metabolic syndrome and often has ALT greater than or equal to AST until advanced disease.
- C. Primary biliary cholangitis is cholestatic autoimmune bile duct disease.
- D. Wilson disease is copper accumulation in a younger patient.
- E. HAV is acute fecal-oral hepatitis.
Flashcards
Tap a card to flip it.
What AST:ALT pattern favors alcohol-associated liver disease?
AST greater than ALT, often near a 2:1 ratio, supports alcohol-associated disease.
What risk cluster favors MASLD/NAFLD?
Obesity, insulin resistance, type 2 diabetes, dyslipidemia, and metabolic syndrome favor metabolic steatotic liver disease.
Quick answers
What is the fastest way to tell Alcohol-associated fatty liver disease from Metabolic dysfunction-associated steatotic liver disease?
Alcohol exposure and AST:ALT near 2:1 point alcohol-associated disease; metabolic syndrome without alcohol points MASLD/NAFLD.
What is the key clue for Alcohol-associated fatty liver disease?
Fatty liver or steatohepatitis with meaningful alcohol exposure, AST greater than ALT often near 2:1, macrocytosis, or alcoholic hepatitis clues.
What is the key clue for Metabolic dysfunction-associated steatotic liver disease?
Fatty liver disease tied to obesity, insulin resistance, type 2 diabetes, dyslipidemia, and metabolic syndrome without significant alcohol use; older wording is NAFLD.
What is the common trap with Alcohol-associated fatty liver disease vs Metabolic dysfunction-associated steatotic liver disease?
Both can progress from steatosis to steatohepatitis, cirrhosis, and hepatocellular carcinoma.